Skip to main content
Top
Published in: Sleep and Breathing 2/2010

01-06-2010 | Original Article

Submaximal exercise in patients with severe obstructive sleep apnea

Authors: Hatem Alameri, Yusra Al-Kabab, Ahmed BaHammam

Published in: Sleep and Breathing | Issue 2/2010

Login to get access

Abstract

Purpose

Several studies have used the cardiopulmonary exercise test to assess patients with obstructive sleep apnea (OSA). However, no report has investigated the use of the 6-min walk test (6MWT) in this group of patients.

Methods

We studied consecutive, newly diagnosed, OSA patients (aged >18 years). The control group was composed of matched healthy subjects with no clinical history indicative of sleep breathing disorders. The study population was divided into three groups: an OSA group, a control obese group, and a control lean group. The obese controls were gender-, age- (±2 years), height- (±5 cm), and weight- (±2 kg) matched to the OSA patients, while the lean controls were matched in gender, age, and height, but not weight. All patients underwent sleep study at our Sleep Disorders Center. Each subject underwent a single 6MWT within 1 week of the sleep study.

Results

A total of 55 patients were recruited to the OSA group (age 36.7 ± 7.9 years, body mass index 38.7 ± 8.6 kg/m2, and apnea hypopnea index 66.6 ± 34.8/h), 32 subjects to the control obese group, and 30 to the control lean group. There was no difference in distance walked (6-min walk distance (6MWD)) between the OSA group (389 ± 70 m) and the obese group (408 ± 66 m). In the OSA group, the 6MWD results did not correlate with patient age, apnea hypopnea index, or other polysomnographic variables. At the end of the test, heart rate, systolic and diastolic blood pressure, and dyspnea perception were significantly increased in the OSA group compared with healthy subjects.

Conclusions

The 6MWT is easy to perform and well tolerated by patients with OSA. There were no correlations between the 6MWD and the severity of OSA or other polysomnographic parameters. However, patients with OSA exhibited abnormal hemodynamic responses to submaximal exercise.
Literature
1.
go back to reference Jones NL, Killian KJ (2000) Exercise limitation in health and disease. N Engl J Med 343(9):632–641CrossRefPubMed Jones NL, Killian KJ (2000) Exercise limitation in health and disease. N Engl J Med 343(9):632–641CrossRefPubMed
2.
go back to reference Yang EH, Hla KM, McHorney CA, Havighurst T, Badr MS, Weber S (2000) Sleep apnea and quality of life. Sleep 23(4):535–541PubMed Yang EH, Hla KM, McHorney CA, Havighurst T, Badr MS, Weber S (2000) Sleep apnea and quality of life. Sleep 23(4):535–541PubMed
3.
go back to reference Aguillard RN, Riedel BW, Lichstein KL, Grieve FG, Johnson CT, Noe SL (1998) Daytime functioning in obstructive sleep apnea patients: exercise tolerance, subjective fatigue, and sleepiness. Appl Psychophysiol Biofeedback 23(4):207–217CrossRefPubMed Aguillard RN, Riedel BW, Lichstein KL, Grieve FG, Johnson CT, Noe SL (1998) Daytime functioning in obstructive sleep apnea patients: exercise tolerance, subjective fatigue, and sleepiness. Appl Psychophysiol Biofeedback 23(4):207–217CrossRefPubMed
4.
go back to reference Kaleth AS, Chittenden TW, Hawkins BJ, Hargens TA, Guill SG, Zedalis D et al (2007) Unique cardiopulmonary exercise test responses in overweight middle-aged adults with obstructive sleep apnea. Sleep Med 8(2):160–168CrossRefPubMed Kaleth AS, Chittenden TW, Hawkins BJ, Hargens TA, Guill SG, Zedalis D et al (2007) Unique cardiopulmonary exercise test responses in overweight middle-aged adults with obstructive sleep apnea. Sleep Med 8(2):160–168CrossRefPubMed
5.
go back to reference Alonso-Fernandez A, Garcia-Rio F, Arias MA, Mediano O, Pino JM, Martinez I et al (2006) Obstructive sleep apnoea-hypoapnoea syndrome reversibly depresses cardiac response to exercise. Eur Heart J 27(2):207–215CrossRefPubMed Alonso-Fernandez A, Garcia-Rio F, Arias MA, Mediano O, Pino JM, Martinez I et al (2006) Obstructive sleep apnoea-hypoapnoea syndrome reversibly depresses cardiac response to exercise. Eur Heart J 27(2):207–215CrossRefPubMed
6.
go back to reference Vanuxem D, Badier M, Guillot C, Delpierre S, Jahjah F, Vanuxem P (1997) Impairment of muscle energy metabolism in patients with sleep apnoea syndrome. Respir Med 91(9):551–557CrossRefPubMed Vanuxem D, Badier M, Guillot C, Delpierre S, Jahjah F, Vanuxem P (1997) Impairment of muscle energy metabolism in patients with sleep apnoea syndrome. Respir Med 91(9):551–557CrossRefPubMed
7.
go back to reference Cahalin LP, Mathier MA, Semigran MJ, Dec GW, DiSalvo TG (1996) The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 110(2):325–332CrossRefPubMed Cahalin LP, Mathier MA, Semigran MJ, Dec GW, DiSalvo TG (1996) The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 110(2):325–332CrossRefPubMed
8.
go back to reference Kadikar A, Maurer J, Kesten S (1997) The six-minute walk test: a guide to assessment for lung transplantation. J Heart Lung Transplant 16(3):313–319PubMed Kadikar A, Maurer J, Kesten S (1997) The six-minute walk test: a guide to assessment for lung transplantation. J Heart Lung Transplant 16(3):313–319PubMed
9.
go back to reference Roul G, Germain P, Bareiss P (1998) Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure? Am Heart J 136(3):449–457CrossRefPubMed Roul G, Germain P, Bareiss P (1998) Does the 6-minute walk test predict the prognosis in patients with NYHA class II or III chronic heart failure? Am Heart J 136(3):449–457CrossRefPubMed
10.
go back to reference Hoeper MM, Schwarze M, Ehlerding S, Adler-Schuermeyer A, Spiekerkoetter E, Niedermeyer J et al (2000) Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl J Med 342(25):1866–1870CrossRefPubMed Hoeper MM, Schwarze M, Ehlerding S, Adler-Schuermeyer A, Spiekerkoetter E, Niedermeyer J et al (2000) Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl J Med 342(25):1866–1870CrossRefPubMed
11.
go back to reference Flaherty KR, Andrei AC, Murray S, Fraley C, Colby TV, Travis WD et al (2006) Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six minute hallwalk. Am J Respir Crit Care Med 174(7):803–809CrossRefPubMed Flaherty KR, Andrei AC, Murray S, Fraley C, Colby TV, Travis WD et al (2006) Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six minute hallwalk. Am J Respir Crit Care Med 174(7):803–809CrossRefPubMed
12.
go back to reference Alameri H, Al-Majed S, Al-Howaikan A (2009) Six-min walk test in a healthy adult Arab population. Respir Med 103(7):1041–1046CrossRefPubMed Alameri H, Al-Majed S, Al-Howaikan A (2009) Six-min walk test in a healthy adult Arab population. Respir Med 103(7):1041–1046CrossRefPubMed
13.
go back to reference Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP (1999) Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 131(7):485–491PubMed Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP (1999) Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 131(7):485–491PubMed
14.
go back to reference Rechtschaffen A, Kales A (eds) (1968) A manual of standardized terminology techniques and scoring system for sleep stages of human subjects. NIH Publication number 204, US Government Printing Office, Washington Rechtschaffen A, Kales A (eds) (1968) A manual of standardized terminology techniques and scoring system for sleep stages of human subjects. NIH Publication number 204, US Government Printing Office, Washington
15.
go back to reference American Sleep Disorders Association, Atlas task Force (1992) EEG arousals: scoring rules and examples. Sleep 15:174–184 American Sleep Disorders Association, Atlas task Force (1992) EEG arousals: scoring rules and examples. Sleep 15:174–184
16.
go back to reference International Classification of Sleep Disorders (2005) Diagnostic & coding manual, 2nd edn. American Academy of Sleep Medicine, Westchester (IL) International Classification of Sleep Disorders (2005) Diagnostic & coding manual, 2nd edn. American Academy of Sleep Medicine, Westchester (IL)
17.
go back to reference American Academy of Sleep Medicine Task Force (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22:667–689 American Academy of Sleep Medicine Task Force (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22:667–689
18.
go back to reference American Thoracic Society (1995) Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 152:1107–1136 American Thoracic Society (1995) Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 152:1107–1136
19.
go back to reference American Thoracic Society (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–117 American Thoracic Society (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–117
20.
go back to reference Edward Shifflett D, Walker EW, Gregg JM, Zedalis D, Herbert WG (2001) Effects of short-term PAP treatment on endurance exercise performance in obstructive sleep apnea patients. Sleep Med 2(2):145–151CrossRefPubMed Edward Shifflett D, Walker EW, Gregg JM, Zedalis D, Herbert WG (2001) Effects of short-term PAP treatment on endurance exercise performance in obstructive sleep apnea patients. Sleep Med 2(2):145–151CrossRefPubMed
21.
go back to reference Grote L, Hedner J, Peter JH (2004) The heart rate response to exercise is blunted in patients with sleep-related breathing disorder. Cardiology 102(2):93–99CrossRefPubMed Grote L, Hedner J, Peter JH (2004) The heart rate response to exercise is blunted in patients with sleep-related breathing disorder. Cardiology 102(2):93–99CrossRefPubMed
22.
go back to reference Lin CC, Lin CK, Wu KM, Chou CS (2004) Effect of treatment by nasal CPAP on cardiopulmonary exercise test in obstructive sleep apnea syndrome. Lung 182(4):199–212CrossRefPubMed Lin CC, Lin CK, Wu KM, Chou CS (2004) Effect of treatment by nasal CPAP on cardiopulmonary exercise test in obstructive sleep apnea syndrome. Lung 182(4):199–212CrossRefPubMed
23.
go back to reference Lin CC, Hsieh WY, Chou CS, Liaw SF (2006) Cardiopulmonary exercise testing in obstructive sleep apnea syndrome. Respir Physiol Neurobiol 150(1):27–34CrossRefPubMed Lin CC, Hsieh WY, Chou CS, Liaw SF (2006) Cardiopulmonary exercise testing in obstructive sleep apnea syndrome. Respir Physiol Neurobiol 150(1):27–34CrossRefPubMed
24.
go back to reference Tryfon S, Stanopoulos I, Dascalopoulou E, Argyropoulou P, Bouros D, Mavrofridis E (2004) Sleep apnea syndrome and diastolic blood pressure elevation during exercise. Respiration 71(5):499–504CrossRefPubMed Tryfon S, Stanopoulos I, Dascalopoulou E, Argyropoulou P, Bouros D, Mavrofridis E (2004) Sleep apnea syndrome and diastolic blood pressure elevation during exercise. Respiration 71(5):499–504CrossRefPubMed
25.
go back to reference Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK (1998) Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98(8):772–776PubMed Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK (1998) Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98(8):772–776PubMed
26.
go back to reference Somers VK, Dyken ME, Mark AL, Abboud FM (1993) Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 328(5):303–307CrossRefPubMed Somers VK, Dyken ME, Mark AL, Abboud FM (1993) Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 328(5):303–307CrossRefPubMed
27.
go back to reference Hargens TA, Guill SG, Zedalis D, Gregg JM, Nickols-Richardson SM, Herbert WG (2008) Attenuated heart rate recovery following exercise testing in overweight young men with untreated obstructive sleep apnea. Sleep 31(1):104–110PubMed Hargens TA, Guill SG, Zedalis D, Gregg JM, Nickols-Richardson SM, Herbert WG (2008) Attenuated heart rate recovery following exercise testing in overweight young men with untreated obstructive sleep apnea. Sleep 31(1):104–110PubMed
28.
go back to reference Maeder MT, Munzer T, Rickli H, Schoch OD, Korte W, Hurny C et al (2008) Association between heart rate recovery and severity of obstructive sleep apnea syndrome. Sleep Med 9(7):753–761CrossRefPubMed Maeder MT, Munzer T, Rickli H, Schoch OD, Korte W, Hurny C et al (2008) Association between heart rate recovery and severity of obstructive sleep apnea syndrome. Sleep Med 9(7):753–761CrossRefPubMed
29.
go back to reference Vanhecke TE, Franklin BA, Zalesin KC, Sangal RB, deJong AT, Agrawal V et al (2008) Cardiorespiratory fitness and obstructive sleep apnea syndrome in morbidly obese patients. Chest 134(3):539–545CrossRefPubMed Vanhecke TE, Franklin BA, Zalesin KC, Sangal RB, deJong AT, Agrawal V et al (2008) Cardiorespiratory fitness and obstructive sleep apnea syndrome in morbidly obese patients. Chest 134(3):539–545CrossRefPubMed
Metadata
Title
Submaximal exercise in patients with severe obstructive sleep apnea
Authors
Hatem Alameri
Yusra Al-Kabab
Ahmed BaHammam
Publication date
01-06-2010
Publisher
Springer-Verlag
Published in
Sleep and Breathing / Issue 2/2010
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-009-0300-4

Other articles of this Issue 2/2010

Sleep and Breathing 2/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine